ANIP vs PRGO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ANIP · ANI Pharmaceuticals$68.55 ▼ 0.84%
PRGO · Perrigo$15.94 ▼ 0.62%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ANIP -15.3%
- PRGO +34.4%
Head to head
| Metric | ANIP | PRGO |
|---|---|---|
| Price | $68.55 | $15.94 |
| Change today | ▼ 0.84% | ▼ 0.62% |
| Market cap | $1.56B | $2.21B |
| Return, 3 months | -7.6% | +14.0% |
| Return, year to date | -13.2% | +22.6% |
| Return, 1 year | -14.0% | +35.0% |
| P/E (TTM) | 13.6 | – |
| P/B | 2.4 | 0.9 |
| P/E percentile vs own 5y | 60th | 87th |
| Dividend yield | – | 7.28% |
| Revenue growth (YoY, latest qtr) | +27.6% | -5.2% |
| Net profit growth (YoY) | +32.1% | -466.7% |
| Gross margin | 61.1% | 32.3% |
| Operating margin | 15.3% | 4.5% |
| Net margin | 10.6% | -43.3% |
| Return on equity | 19.2% | -51.4% |
| Analyst target vs. price | +53.4% | +19.2% |
| Analyst buy share | 71% | 100% |
| RSI (14) | 41 | 50 |
| 30-day volatility | 31.3% | 42.5% |
| Max drawdown, 1 year | -24.2% | -37.7% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PRGO is the largest of the group by market value.
- PRGO has returned the most over the past year.
- ANIP is growing revenue fastest.
- ANIP keeps the most profit per dollar of sales.
- ANIP has been the calmest stock over the last 30 days.